Ipca Laboratories Ltd vs Jeena Sikho Lifecare Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 03, 2026

Key Highlights

The Latest Trading Price of Ipca Laboratories Ltd is ₹ 1531 as of 30 Apr 15:30 . The P/E Ratio of Ipca Laboratories Ltd changed from 21.2 on March 2021 to 51.6 on March 2025 . This represents a CAGR of 19.47% over 5 yearsThe P/E Ratio of Jeena Sikho Lifecare Ltd changed from 11.8 on March 2023 to 0 on March 2025 . This represents a CAGR of -100.00% over 3 years The Market Cap of Ipca Laboratories Ltd changed from ₹ 24137 crore on March 2021 to ₹ 38088 crore on March 2025 . This represents a CAGR of 9.55% over 5 yearsThe Market Cap of Jeena Sikho Lifecare Ltd changed from ₹ 400.11 crore on March 2023 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 3 years The revenue of Ipca Laboratories Ltd for the Dec '25 is ₹ 2430 crore as compare to the Sep '25 revenue of ₹ 2584 crore. This represent the decline of -5.96% The revenue of Jeena Sikho Lifecare Ltd for the Dec '25 is ₹ 224.25 crore as compare to the Sep '25 revenue of ₹ 191.29 crore. This represent the growth of 17.23% The ebitda of Ipca Laboratories Ltd for the Dec '25 is ₹ 571.19 crore as compare to the Sep '25 ebitda of ₹ 514.52 crore. This represent the growth of 11.01% The ebitda of Jeena Sikho Lifecare Ltd for the Dec '25 is ₹ 103.29 crore as compare to the Sep '25 ebitda of ₹ 93.47 crore. This represent the growth of 10.51% The net profit of Ipca Laboratories Ltd changed from ₹ 198.98 crore to ₹ 364.05 crore over 7 quarters. This represents a CAGR of 41.23% The net profit of Jeena Sikho Lifecare Ltd changed from ₹ 15.73 crore to ₹ 66.6 crore over 7 quarters. This represents a CAGR of 128.11% The Dividend Payout of Ipca Laboratories Ltd changed from 8.9 % on March 2021 to 15.59 % on March 2025 . This represents a CAGR of 11.86% over 5 yearsThe Dividend Payout of Jeena Sikho Lifecare Ltd changed from 8.19 % on March 2023 to 14.99 % on March 2025 . This represents a CAGR of 22.32% over 3 years .

About Ipca Laboratories Ltd

Ipca Laboratories Limited (IPCA) was incorporated on 19 October, 1949 under the name of 'The Indian Pharmaceutical Combine Association Limited.' Ipca is a fully integrated, pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments.
The products of the Company are now sold in over 100 countries across the globe.
The Company has 18 manufacturing units in India manufacturing API's and formulations for the world market. Ipca's APIs and Formulations produced at world class manufacturing facilities are approved by leading drug regulatory authorities including the US-Food and Drug Administration (FDA), UK-Medicines and Healthcare products Regulatory Agency (MHRA), South Africa-Medicines Control Council (MCC), Brazil-Brazilian National Health Vigilance Agency (ANVISA) and Australia-Therapeutic Goods Administration (TGA) with operations in over 100 countries.

About Jeena Sikho Lifecare Ltd

Jeena Sikho Lifecare Limited was originally incorporated as a Private Limited Company as 'Jeena Sikho Lifecare Private Limited' dated May 29, 2017 issued by the Registrar of Companies, Delhi.
Subsequently, the Company got the status converted into Public Limited Company and the name was changed to 'Jeena Sikho Lifecare Limited' dated July 05, 2021, via fresh Certificate of Incorporation. Jeena Sikho Lifecare Limited is a renowned Ayurvedic healthcare company headquartered in Zirakpur, Punjab.
The Company is one of the leading ayurvedic healthcare system providers in India.
The Company is selling more than 250 Herbal/ Ayurvedic products.
The Company conducts various health checkup camps, yoga sessions to make people aware of their health problems as well.

FAQs for the comparison of Ipca Laboratories Ltd and Jeena Sikho Lifecare Ltd

Which company has a larger market capitalization, Ipca Laboratories Ltd or Jeena Sikho Lifecare Ltd?

Market cap of Ipca Laboratories Ltd is 38,847 Cr while Market cap of Jeena Sikho Lifecare Ltd is 8,389 Cr

What are the key factors driving the stock performance of Ipca Laboratories Ltd and Jeena Sikho Lifecare Ltd?

The stock performance of Ipca Laboratories Ltd and Jeena Sikho Lifecare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Ipca Laboratories Ltd and Jeena Sikho Lifecare Ltd?

As of May 3, 2026, the Ipca Laboratories Ltd stock price is INR ₹1531.2. On the other hand, Jeena Sikho Lifecare Ltd stock price is INR ₹674.9.

How do dividend payouts of Ipca Laboratories Ltd and Jeena Sikho Lifecare Ltd compare?

To compare the dividend payouts of Ipca Laboratories Ltd and Jeena Sikho Lifecare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.